Literature DB >> 15902563

Orthotopic liver transplantation from a living-related donor in an infant with a peroxisome biogenesis defect of the infantile Refsum disease type.

L Van Maldergem1, A B Moser, M-F Vincent, D Roland, R Reding, J-B Otte, R J Wanders, E Sokal.   

Abstract

Peroxisomal biogenesis defects include a number of severe neurodevelopmental disorders, among which infantile Refsum disease (IRD) occupies the mildest end of the spectrum. Although high docosahexaenoic acid (DHA) and low phytanic acid diets can correct some of the biochemical defects, they have not consistently altered the progressive course of the disease. We carried out orthotopic liver transplantation (OLT) in a mildly symptomatic 6-month-old infant who was a sibling of a severely neurologically impaired older sister. After transplantation the clinical course of this young child appeared much improved by comparison to her older sister. She walked alone at 4 years, had acceptable social interaction and had a noticeable recovery of audition. After transplantation her biochemical parameters were significantly improved: phytanic acid and very long-chain fatty acid (VLCFA) serum concentrations decreased. Abnormal bile acids disappeared from plasma. Although the OLT did not result in a cure of the disorder, the clinical and biochemical results suggest that OLT should be considered in mildly symptomatic patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902563     DOI: 10.1007/s10545-005-0593-9

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

Review 1.  Recent advances in liver transplantation for metabolic disease.

Authors:  P J Mc Kiernan
Journal:  J Inherit Metab Dis       Date:  2017-02-06       Impact factor: 4.982

2.  Liver transplantation for inborn errors of liver metabolism.

Authors:  Efienne M Sokal
Journal:  J Inherit Metab Dis       Date:  2006 Apr-Jun       Impact factor: 4.982

Review 3.  Liver transplantation for non-hepatotoxic inborn errors of metabolism.

Authors:  William R Treem
Journal:  Curr Gastroenterol Rep       Date:  2006-06

Review 4.  Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.

Authors:  Mousumi Bose; Christine Yergeau; Yasmin D'Souza; David D Cuthbertson; Melisa J Lopez; Alyssa K Smolen; Nancy E Braverman
Journal:  Cells       Date:  2022-06-10       Impact factor: 7.666

Review 5.  Therapeutic hepatocyte transplant for inherited metabolic disorders: functional considerations, recent outcomes and future prospects.

Authors:  Kara R Vogel; Andrew A Kennedy; Luke A Whitehouse; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2013-10-02       Impact factor: 4.982

Review 6.  Zellweger spectrum disorders: clinical overview and management approach.

Authors:  Femke C C Klouwer; Kevin Berendse; Sacha Ferdinandusse; Ronald J A Wanders; Marc Engelen; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2015-12-01       Impact factor: 4.123

7.  Age-dependent glycosylation of the sodium taurocholate cotransporter polypeptide: From fetal to adult human livers.

Authors:  Camillo Sargiacomo; Hoda El-Kehdy; Guillaume Pourcher; Bruno Stieger; Mustapha Najimi; Etienne Sokal
Journal:  Hepatol Commun       Date:  2018-04-06

8.  High Dose Versus Low Dose Syngeneic Hepatocyte Transplantation in Pex1-G844D NMRI Mouse Model is Safe but Does Not Achieve Long Term Engraftment.

Authors:  Tanguy Demaret; Jonathan Evraerts; Joachim Ravau; Martin Roumain; Giulio G Muccioli; Mustapha Najimi; Etienne M Sokal
Journal:  Cells       Date:  2020-12-30       Impact factor: 6.600

Review 9.  The Key Role of Peroxisomes in Follicular Growth, Oocyte Maturation, Ovulation, and Steroid Biosynthesis.

Authors:  Shan Wang; HaoXuan Yang; YongLun Fu; XiaoMing Teng; ChiChiu Wang; WenMing Xu
Journal:  Oxid Med Cell Longev       Date:  2022-02-03       Impact factor: 6.543

10.  Peroxisome biogenesis disorders.

Authors:  Catherine Argyriou; Maria Daniela D'Agostino; Nancy Braverman
Journal:  Transl Sci Rare Dis       Date:  2016-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.